Back
America Movil SAB de CV Vs. Cidara Therapeutics Industry Stock Comparison
Sell
50
AMX
America Movil SAB de CV
Last Price:
$18.17
Seasonality Move:
-0.93%
Buy
70
CDTX
Cidara Therapeutics
Last Price:
$62.71
Seasonality Move:
-9.13%
Sell
50
America Movil SAB de CV (AMX)
is a Sell
Is America Movil SAB de CV a Buy, Sell or Hold?
-
The current America Movil SAB de CV [AMX] share price is $18.18. The Score for AMX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
AMX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $61.85. The Score for CDTX is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AMX Stock Price Chart
What is America Movil SAB de CV's stock price today?
-
The America Movil SAB de CV share price today is $18.18Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AMX is experiencing slight selling pressure.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $61.85Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
AMX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.18 | Buy |
Relative Strength Index (14 RSI): | 60.45 | Buy |
Chaikin Money Flow: | -735770 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.24 - 18.06) | Buy |
Bollinger Bands (100): | (14.96 - 17.82) | Buy |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.15 | Buy |
Relative Strength Index (14 RSI): | 70.27 | Buy |
Chaikin Money Flow: | -100733 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
AMX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.69 | Buy |
20-day SMA: | 17.73 | Buy |
50-day SMA: | 17.43 | Buy |
200-day SMA: | 15.69 | Buy |
8-day EMA: | 17.9 | Buy |
20-day EMA: | 17.68 | Buy |
50-day EMA: | 17.31 | Buy |
200-day EMA: | 16.41 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 59.56 | Buy |
20-day SMA: | 53.91 | Buy |
50-day SMA: | 37.68 | Buy |
200-day SMA: | 24 | Buy |
8-day EMA: | 59.74 | Buy |
20-day EMA: | 53.31 | Buy |
50-day EMA: | 42.08 | Buy |
200-day EMA: | 26.97 | Buy |
America Movil SAB de CV Earnings Growth & AMX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.01 per share, an increase this year of $0.85 per share, and an increase next year of $0.11 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
America Movil SAB de CV Technical Analysis
Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |